Investor Presentaiton

Financial Snapshot Growth in Revenue Growth in EBITDA Q1FY24 Q1FY23 Growth in PAT -5.61% -2.94% -4.51% 1.25% 8.64% 8.98% Comparison with immediate previous quarter and same quarter of previous year SUVEN 6 PHARMA

View entire presentation